Literature DB >> 25167831

Gene-environment interaction and susceptibility in head and neck cancer patients and in their first-degree relatives: a study of Northeast Indian population.

Javed Hussain Choudhury1, Sankar Kumar Ghosh1.   

Abstract

BACKGROUND: The environmental and genetic factors are known to be associated with head and neck squamous cell carcinoma (HNSCC). Here, we investigated the GSTM1 and GSTT1 polymorphisms and tobacco uses in patients and in their first-degree relatives to evaluate susceptibility toward HNSCC. Further, we explored high-risk interaction between genetic and environmental risk factors. SUBJECTS AND METHODS: Genotyping of GSTM1 and GSTT1 was performed in 170 patients, 300 first-degree relatives of patients and 300 controls using multiplex PCR. Multifactor dimensionality reduction (MDR) and logistic regression approach were applied for statistical analysis.
RESULTS: Analysis revealed that GSTM1 and GSTT1 null genotype frequencies were significantly higher in patients (adjusted odds ratio (OR) = 2.18; P < 0.001 and OR = 1.61; P = 0.031, respectively). Also, the GSTM1 and GSTT1 null genotype frequencies were significantly higher in first-degree relatives of patients compared with controls (P = 0.004 and P = 0.041, respectively). In MDR analysis, the best model for HNSCC risk was four-factors model of tobacco, betel quid chewing, smoking and GSTM1 null genotypes (cross-validation consistency = 10/10 and P < 0.0001), whereas in interaction entropy graphs, tobacco chewing and GSTM1 null genotype further showed strongest synergistic interaction.
CONCLUSION: GSTM1 and GSTT1 null genotypes may act as markers to determine the genetic susceptibility in HNSCC patients and in their first-degree relatives. Furthermore, tobacco chewing and GSTM1 null genotype interaction identified as the strongest gene-environment model to predict HNSCC.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  GSTM1-GSTT1 polymorphism; MDR analysis; first-degree relatives; head and neck squamous cell carcinoma; tobacco habits

Mesh:

Substances:

Year:  2014        PMID: 25167831     DOI: 10.1111/jop.12249

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  7 in total

1.  Tobacco carcinogen-metabolizing genes CYP1A1, GSTM1, and GSTT1 polymorphisms and their interaction with tobacco exposure influence the risk of head and neck cancer in Northeast Indian population.

Authors:  Javed Hussain Choudhury; Seram Anil Singh; Sharbadeb Kundu; Biswadeep Choudhury; Fazlur R Talukdar; Shilpee Srivasta; Ruhina S Laskar; Bishal Dhar; Raima Das; Shaheen Laskar; Manish Kumar; Wetetsho Kapfo; Rosy Mondal; Sankar Kumar Ghosh
Journal:  Tumour Biol       Date:  2015-02-28

2.  A novel environmental exposure index and its interaction with familial susceptibility on oral cancer in non-smokers and non-drinkers: a case-control study.

Authors:  Lingjun Yan; Fa Chen; Baochang He; Fengqiong Liu; Fangping Liu; Jiangfeng Huang; Junfeng Wu; Lisong Lin; Yu Qiu; Lin Cai
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-12-19       Impact factor: 2.503

3.  Promoter Hypermethylation Profiling Identifies Subtypes of Head and Neck Cancer with Distinct Viral, Environmental, Genetic and Survival Characteristics.

Authors:  Javed Hussain Choudhury; Sankar Kumar Ghosh
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

Review 4.  Does CYP2E1 RsaI/PstI polymorphism confer head and neck carcinoma susceptibility?: A meta-analysis based on 43 studies.

Authors:  Xianlu Zhuo; Jue Song; Jian Liao; Wei Zhou; Huiping Ye; Qi Li; Zhaolan Xiang; Xueyuan Zhang
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

5.  Prognostic and clinicopathological significance of MUC expression in head and neck cancer: a systematic review and meta-analysis.

Authors:  Hao Lu; Dan Liang; Yun Zhu; Wanlin Xu; Kaihua Zhou; Limin Liu; Shengwen Liu; Wenjun Yang
Journal:  Oncotarget       Date:  2017-07-27

6.  Associations among smoking, MGMT hypermethylation, TP53-mutations, and relapse in head and neck squamous cell carcinoma.

Authors:  Shinichi Matsuda; Aki Mafune; Nagisa Kohda; Takanori Hama; Mitsuyoshi Urashima
Journal:  PLoS One       Date:  2020-04-23       Impact factor: 3.240

7.  Is MDM2 SNP309 Variation a Risk Factor for Head and Neck Carcinoma?: An Updated Meta-Analysis Based on 11,552 Individuals.

Authors:  Xianlu Zhuo; Huiping Ye; Qi Li; Zhaolan Xiang; Xueyuan Zhang
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.